264 related articles for article (PubMed ID: 25887336)
1. Efficacy and safety of a single oral 150 mg dose of fluconazole for the treatment of vulvovaginal candidiasis in Japan.
Mikamo H; Matsumizu M; Nakazuru Y; Okayama A; Nagashima M
J Infect Chemother; 2015 Jul; 21(7):520-6. PubMed ID: 25887336
[TBL] [Abstract][Full Text] [Related]
2. Comparative study of fluconazole and clotrimazole for the treatment of vulvovaginal candidiasis.
O-Prasertsawat P; Bourlert A
Sex Transm Dis; 1995; 22(4):228-30. PubMed ID: 7482105
[TBL] [Abstract][Full Text] [Related]
3. An evaluation of butoconazole nitrate 2% site release vaginal cream (Gynazole-1) compared to fluconazole 150 mg tablets (Diflucan) in the time to relief of symptoms in patients with vulvovaginal candidiasis.
Seidman LS; Skokos CK
Infect Dis Obstet Gynecol; 2005 Dec; 13(4):197-206. PubMed ID: 16338779
[TBL] [Abstract][Full Text] [Related]
4. Phase 3 study evaluating the safety and efficacy of oteseconazole in the treatment of recurrent vulvovaginal candidiasis and acute vulvovaginal candidiasis infections.
Martens MG; Maximos B; Degenhardt T; Person K; Curelop S; Ghannoum M; Flynt A; Brand SR
Am J Obstet Gynecol; 2022 Dec; 227(6):880.e1-880.e11. PubMed ID: 35863457
[TBL] [Abstract][Full Text] [Related]
5. The efficacy and safety of clotrimazole vaginal tablet vs. oral fluconazole in treating severe vulvovaginal candidiasis.
Zhou X; Li T; Fan S; Zhu Y; Liu X; Guo X; Liang Y
Mycoses; 2016 Jul; 59(7):419-28. PubMed ID: 27073145
[TBL] [Abstract][Full Text] [Related]
6. Phase 2 Randomized Study of Oral Ibrexafungerp Versus Fluconazole in Vulvovaginal Candidiasis.
Nyirjesy P; Schwebke JR; Angulo DA; Harriott IA; Azie NE; Sobel JD
Clin Infect Dis; 2022 Jul; 74(12):2129-2135. PubMed ID: 34555149
[TBL] [Abstract][Full Text] [Related]
7. Pattern of Candida species isolated from patients with diabetes mellitus and vulvovaginal candidiasis and their response to single dose oral fluconazole therapy.
Goswami D; Goswami R; Banerjee U; Dadhwal V; Miglani S; Lattif AA; Kochupillai N
J Infect; 2006 Feb; 52(2):111-7. PubMed ID: 15908007
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of Candida glabrata and its response to boric acid vaginal suppositories in comparison with oral fluconazole in patients with diabetes and vulvovaginal candidiasis.
Ray D; Goswami R; Banerjee U; Dadhwal V; Goswami D; Mandal P; Sreenivas V; Kochupillai N
Diabetes Care; 2007 Feb; 30(2):312-7. PubMed ID: 17259500
[TBL] [Abstract][Full Text] [Related]
9. CD101 Topical Compared With Oral Fluconazole for Acute Vulvovaginal Candidiasis: A Randomized Controlled Trial.
Nyirjesy P; Alessio C; Jandourek A; Lee JD; Sandison T; Sobel JD
J Low Genit Tract Dis; 2019 Jul; 23(3):226-229. PubMed ID: 30893271
[TBL] [Abstract][Full Text] [Related]
10. Oral fluconazole and vulvovaginal candidiasis: prevention is not always better than cure.
Prescrire Int; 2013 Sep; 22(141):205. PubMed ID: 24171211
[TBL] [Abstract][Full Text] [Related]
11. A clinical multicenter study comparing efficacy and tolerability of topical combination therapy with clotrimazole (Canesten, two formats) with oral single dose fluconazole (Diflucan) in vulvovaginal mycoses.
Mendling W; Krauss C; Fladung B
Mycoses; 2004 Apr; 47(3-4):136-42. PubMed ID: 15078430
[TBL] [Abstract][Full Text] [Related]
12. A randomized clinical trial of the efficacy and safety of terconazole vaginal suppository versus oral fluconazole for treating severe vulvovaginal candidiasis.
Li T; Zhu Y; Fan S; Liu X; Xu H; Liang Y
Med Mycol; 2015 Jun; 53(5):455-61. PubMed ID: 25877666
[TBL] [Abstract][Full Text] [Related]
13. Oral fluconazole 150 mg single dose versus intra-vaginal clotrimazole treatment of acute vulvovaginal candidiasis.
Sekhavat L; Tabatabaii A; Tezerjani FZ
J Infect Public Health; 2011 Sep; 4(4):195-9. PubMed ID: 22000847
[TBL] [Abstract][Full Text] [Related]
14. Vaginal nystatin versus oral fluconazole for the treatment for recurrent vulvovaginal candidiasis.
Fan S; Liu X; Wu C; Xu L; Li J
Mycopathologia; 2015 Feb; 179(1-2):95-101. PubMed ID: 25416649
[TBL] [Abstract][Full Text] [Related]
15. [Comparative study of itraconazole and fluconazole therapy in vaginal candidosis].
Vacheva-Dobrevski R; Kovachev S; Nacheva A; Stoev S; Vasilev N
Akush Ginekol (Sofiia); 2004; 43(1):20-3. PubMed ID: 15168649
[TBL] [Abstract][Full Text] [Related]
16. A phase 2, randomized, double-blind, placebo-controlled, dose-ranging study to evaluate the efficacy and safety of orally administered VT-1161 in the treatment of recurrent vulvovaginal candidiasis.
Brand SR; Degenhardt TP; Person K; Sobel JD; Nyirjesy P; Schotzinger RJ; Tavakkol A
Am J Obstet Gynecol; 2018 Jun; 218(6):624.e1-624.e9. PubMed ID: 29534874
[TBL] [Abstract][Full Text] [Related]
17. [Treatment of chronic recurrent vulvovaginal candidiasis with fluconazole (fungolon--Actavis)].
Borisov I; Kolarov G; Bobcheva S; Ivanova A
Akush Ginekol (Sofiia); 2005; 44 Suppl 2():17-20. PubMed ID: 16028398
[TBL] [Abstract][Full Text] [Related]
18. Guideline: vulvovaginal candidosis (AWMF 015/072), S2k (excluding chronic mucocutaneous candidosis).
Mendling W; Brasch J; Cornely OA; Effendy I; Friese K; Ginter-Hanselmayer G; Hof H; Mayser P; Mylonas I; Ruhnke M; Schaller M; Weissenbacher ER
Mycoses; 2015 Mar; 58 Suppl 1():1-15. PubMed ID: 25711406
[TBL] [Abstract][Full Text] [Related]
19. Management of chronic vulvovaginal candidiasis: a long term retrospective study.
Nguyen Y; Lee A; Fischer G
Australas J Dermatol; 2017 Nov; 58(4):e188-e192. PubMed ID: 27250078
[TBL] [Abstract][Full Text] [Related]
20. [Combined single-day treatment in acute vulvovaginal candidosis].
Kovachev S; Nacheva A; Vacheva-Dobrevska R; Vasilev N
Akush Ginekol (Sofiia); 2009; 48(6):18-23. PubMed ID: 20225492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
